Your Recent Quotes: 0 | 0

Genentech Inc

Related Information and Financials
Price Glossary Definition
98.75 0.30
0.30%
8/29/08 4:01
Open
98.20
Prev Close
98.45
Volume
1,747,271
52 Wk. Range
65.35-99.14
Year-to-Date Performance Glossary Definition
UP  46.79%
Latest Dividend
Dividend
N/A
Yield
N/A
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
33.41
 
34.00
 
20.30
DNA
Sect. Av.
S&P 500
Market Cap
103,348,135,000
Outstanding Shares
1,053,247,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy DNA Rating Report
Target Price (1Yr)
High
104.00
Revenue
13.43B

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
26.30
1.54
0.36
Net Income
31.00
2.53
0.52
EPS
31.50
2.55
0.52

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
44.65
34.90
9.62
Earnings Per Share($)

12/2005
 
 
 
1.21
12/2006
 
 
 
2.01
12/2007
 
 
 
2.63

Earnings
EBITDA
4.86B
Revenue
11.72B
Outside Analyst Rating History

8/29/08
12
Buy
8/29/08
6
Hold
8/29/08
0
Sell

Jim Cramer Portfolio
Find out now if DNA is in Jim's personal portfolio at Action Alerts PLUS.
Compare This Stock
Latest Headlines
HLTH upgraded; Carrizo Oil & Gas, Genentech, Kyocera and Linn Energy downgraded.

7:01AM 08/26/08

Shares fall as a voluntary recall of two lots of Daytrana is issued.

3:57PM 08/25/08

The drugmaker is the latest to go shopping in a deal-happy summer.

1:38PM 08/22/08

The Market Vectors Environmental Industry ETF gets a buy rating.

9:33AM 08/22/08

Dan Fitzpatrick examines three stocks viewed on 'Fast Money.' Today's stocks include Amylin, Celgene and Dick's.

08:25PM 08/21/08

Watch Video
Video
Check out legendary billionaire trade Bruce Kovner's holdings.

11:12AM 08/20/08

The company was the best performer on the Amex Pharmaceuticals Index Friday.

5:26PM 08/15/08

If Roche is serious about buying the company, it will need to do much better than $89 a share.

10:09AM 08/15/08

This sector is hot right now, as people look for investments that can hold up amid the market downturn.

10:38AM 08/14/08

Drug company says "no" to Roche's advances, says make a better offer worth considering.

5:16PM 08/13/08

Understanding the Market

Our Experts' Take at RealMoney
Until it breaks down or breaks out, I'd stay away from this tinderbox.

11:00AM 08/29/08

The stock saw a nice move up on good volume, but caution is still the name of the game here.

1:29PM 08/28/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading DNA in his Action Alerts Plus Portfolio?